Feasibility of a Stress Reduction Intervention Study in Sickle Cell Disease
15 juli 2015 uppdaterad av: Miriam O. Ezenwa, University of Illinois at Chicago
Stress is known to trigger acute pain crisis of sickle cell disease (SCD).
SCD is an inherited blood disorder that afflicts about 100,000 people in the United States, and is among the most common lethal genetic diseases in the United States.
Though worldwide in distribution, in the US it is most commonly found in African Americans.
Its best known complication is severe, recurrent relentless pain, often known as pain crisis.
Non-drug treatment for SCD pain such as cognitive coping interventions have been shown to be effective for reducing SCD pain intensity, but they are complicated, multifaceted, and time-consuming.
A simple and cost-effective alternative such as guided imagery (GI) could reduce the effect of stress on SCD pain.
GI is an intervention where patients listen to and view audio-visual recordings while being directed to visualize themselves being immersed in that scene or scenario.
There are no published studies on the use of GI as a simple stress coping intervention or tracking stress in a systematic manner as a trigger for SCD pain.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Studietyp
Interventionell
Inskrivning (Faktisk)
28
Fas
- Inte tillämpbar
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år och äldre (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
- Adults 18 years of age or older,
- Diagnosis of SCD,
- Self-reported pain of at least 3 on a 0-10 scale related to SCD,
- Spoke and read English, and
- Self-identified as being of African or Hispanic descent.
Exclusion Criteria:
- Legally blind or physically unable to complete procedures.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: Guided audio-visual relaxation group
The guided relaxation (GR) intervention included a single 12-min GR video clip we administered to subjects at the baseline visit to determine the immediate effects of GR on stress and pain.
The GR intervention also included six video clips, which ranged from 2 to 20 minutes in length to determine the short-term (2-week) effects of GR on stress and pain.
|
|
|
Inget ingripande: Attention Control group
For the attention control group, subjects engaged in a 12-min computer-based discussion about their sickle cell disease (SCD) experience.
The audio-taped questions and onscreen directions were programmed for self-administration.
Subjects' responses were captured via the microphone so that Data Collectors were not involved in this discussion process, and it was equivalent to the guided relation activity.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Current stress
Tidsram: Immediate (baseline)
|
Stress intensity scale: A 3-item scale that asks patients to report their current, least, and worst stress intensity today, on a scale of 0 to 10, where 0 is "no stress" and 10 is "stress as bad as it could be."
We estimated intervention effects using linear regression with bootstrapping.
|
Immediate (baseline)
|
|
Current pain
Tidsram: Immediate (baseline)
|
PAINReportIt® Pain intensity scale: A 3-item scale that asks patients to report their current, least, and worst pain intensity today, on a scale of 0 to 10, where 0 is "no pain" and 10 is "pain as bad as it could be."
We estimated intervention effects using linear regression with bootstrapping.
|
Immediate (baseline)
|
|
Average stress intensity
Tidsram: Short-term (2 weeks)
|
Stress intensity scale: A 3-item scale that asks patients to report their current, least, and worst stress intensity today, on a scale of 0 to 10, where 0 is "no stress" and 10 is "stress as bad as it could be."
We averaged the three scores to create an average stress intensity score.
We estimated intervention effects using linear regression with bootstrapping.
|
Short-term (2 weeks)
|
|
Composite pain index
Tidsram: Short-term (2 weeks)
|
PAINReportIt® Composite pain index (CPI): A a multidimensional representation of pain calculated by averaging the individual proportional scores for each of the four pain dimensions: (1) number of pain sites; (2) pain intensity; (3) total pain rating index (from the McGill Pain Questionnaire [MPQ], pain quality); and (4) pain pattern score.
the scores for the CPI range from 0 to 100.
We estimated intervention effects using linear regression with bootstrapping.
|
Short-term (2 weeks)
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Utredare
- Huvudutredare: Miriam O Ezenwa, PhD, RN, University of Illinois at Chicago
Publikationer och användbara länkar
Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 november 2013
Primärt slutförande (Faktisk)
1 november 2014
Avslutad studie (Faktisk)
1 november 2014
Studieregistreringsdatum
Först inskickad
13 juli 2015
Först inskickad som uppfyllde QC-kriterierna
15 juli 2015
Första postat (Uppskatta)
17 juli 2015
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
17 juli 2015
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
15 juli 2015
Senast verifierad
1 juli 2015
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- Protocol # 2012-1084
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .